Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
HUMAN PLASMA PROTEIN >95% IMMUNOGLOBULINS
Baxter Healthcare Limited
160 g/l
Solution for Injection
2005-06-24
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0167/121/001 Case No: 2056563 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to BAXTER HEALTHCARE LIMITED CAXTON WAY, THETFORD, NORFOLK IP24 3SE, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product SUBCUVIA 160 G/L. SOLUTION FOR INJECTION. The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 07/01/2009. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 08/01/2009_ _CRN 2056563_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUBCUVIA 160 g/l. Solution for injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Human Normal Immunoglobulin (SC/IMIg) 1 l solution contains: human protein 160 g (of which at least 95% are immunoglobulin) Distribution of IgG subclasses: IgG1 45-75% IgG2 20-45% IgG3 3-10% IgG4 2-8% Maximum IgA content: 4.8 g/l 1 vial of 5 ml contains 0.8 g human protein (of which at least 95 % are immunoglobulin). 1 vial of 10 ml contains 1.6 g human protein (of which at least 95 % are immunoglobulin). For a full list of excipients, see section 6.1. This medicinial product contains 1.2 mg sodium per ml. 3 PHARMAC Lue koko asiakirja